home / stock / nk / nk news


NK News and Press, NantKwest

Stock Information

Company Name: NantKwest
Stock Symbol: NK
Market: NASDAQ

Menu

NK NK Quote NK Short NK News NK Articles NK Message Board
Get NK Alerts

News, Short Squeeze, Breakout and More Instantly...

NK - Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility

Imerys Enters Long-Term Partnership with TotalEnergies for Renewable Power at its Santa Barbara County Facility PR Newswire A TotalEnergies solar and battery storage solution to bring 130-year-old Lompoc industrial site into new era of sustainability and smart energy manag...

NK - ImmunityBio and NantKwest Complete Merger

Creates Leading Immunotherapy and Cell Therapy Company ImmunityBio , Inc. and NantKwest , Inc. ( NASDAQ: NK ), today announced the completion of their previously announced 100% stock-for-stock merger. This follows the satisfaction of all customary closing conditi...

NK - NantKwest (NK) shares climb on approval of ImmunityBio merger

NantKwest (NK) gains 7% premarket after its stockholders approved the proposal related to the pending merger with ImmunityBio.The transaction is expected to close today.The combined company will assume the ImmunityBio name and its common shares are expected to trade on Nasdaq under ...

NK - Stockholders of NantKwest Approve Merger With ImmunityBio

NantKwest, Inc . ( NASDAQ: NK ), a clinical-stage, natural killer cell-based therapeutics company, today announced that its stockholders approved by the required vote each of the proposals related to the pending merger of NantKwest and ImmunityBio, Inc. presented at the special ...

NK - Nantkwest and ImmunityBio start dosing in global COVID-19 vaccine trials

NantKwest (NK) and privately-held ImmunityBio announce that the first cohorts of their South Africa and U.S. COVID-19 vaccine trials have received their initial doses of the T-cell-based COVID-19 vaccine candidate, hAd5.The trials aim to determine which route com...

NK - ImmunityBio and NantKwest Begin Dosing Participants in Global Trials for Novel COVID-19 Vaccine; Subcutaneous Route in South Africa, Oral and Sublingual in the U.S.

One vaccine, three routes for activating the entire immune system and providing T cell, B cell memory, and mucosal protection The first COVID-19 vaccine trials designed to deliver both S and N SARS-CoV-2 viral proteins via multiple routes—subcutaneous, sublingual, and oral ...

NK - SNSE, AGLE, CRWD and ISEE among after-hours movers

Gainers: [[SNSE]] +17.5%. [[ABCL]] +8.3%. [[AGLE]] +7.6%. [[OLED]] +5.9%. [[EOLS]] +5.4%.Losers: [[CRWD]] -7.0%. [[ARDX]] -6.9%. [[NK]] -6.6%. [[CATB]] -3.2%. [[ISEE]] -3.1%. For further details see: SNSE, AGLE, CRWD and ISEE among after-hours movers

NK - All Three Independent Proxy Advisory Firms - ISS, Glass Lewis and Egan-Jones - Recommend NantKwest Stockholders Vote "FOR" the Pending Merger With ImmunityBio

The NantKwest Special Committee and the NantKwest Board of Directors recommend stockholders vote “FOR” the transaction in advance of the virtual special meeting scheduled for March 8, 2021 at 9:30 a.m. Pacific Time Stockholders are encouraged to vote, no matter...

NK - ImmunityBio Announces ASCO Genitourinary Cancer Symposium Presentation of Phase 2/3 Trial for BCG Unresponsive Non-Muscle Invasive Bladder Cancer CIS with 71% Complete Response Rate

QUILT 3.032 study completes planned enrollment of BCG unresponsive non-muscle invasive bladder cancer CIS cohort with 59% probability of patients maintaining complete response for at least 12 months Over 87.5% of patients in this study have avoided a cystectomy to date FDA...

NK - The Crypto Party Rages On

Stocks rose this week, with investors piling into growth-oriented segments of the market. At the time of this recording, the S&P 500 (SP500) and Dow Industrials (DJI) were up 0.3% and 0.1% for the week, respectively. The Nasdaq (COMP) rallied by 0.9% while cryptocurrencies (and crypto sto...

Next 10